Drug profile
Here's what the FDA CVM extract says about Ivermectin 136Mcg, Pyrantel Pamoate 114Mg, Praziquantel 114Mg
The CVM extract lists 950 reports for Ivermectin 136Mcg, Pyrantel Pamoate 114Mg, Praziquantel 114Mg, a high-volume entry. Species, reactions, and outcomes are below.
- #191 of 2,679
- by report volume (all drugs)
- 950
- adverse-event reports
- 1.4%
- death-coded share
- Dog
- most-reported species
Corpus placement
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Ivermectin 136Mcg, Pyrantel Pamoate 114Mg, Praziquantel 114Mg ranks #191 of 2679 by total reports (950) and #1041 of 1130 by death-coded share (1.4%). National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).
- 149,624
- Milbemycin Oxime + Spinosad reports (#1)
- 97.8%
- Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
- #191
- This drug, reports of 2679
- #1041
- This drug, death share of 1130
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
What changed in the latest FDA data snapshot
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Ivermectin 136Mcg, Pyrantel Pamoate 114Mg, Praziquantel 114Mg has 950 reports now versus 950 in that prior snapshot: 0 the same number of (0.0%).
- Report change
- +0
- Death-coded reports
- +0
- Death-coded share
- +0.0 pts
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Ivermectin 136Mcg, Pyrantel Pamoate 114Mg, Praziquantel 114Mg changesSignature read: 950 reports place Ivermectin 136Mcg, Pyrantel Pamoate 114Mg, Praziquantel 114Mg in the upper third of FDA AER volume (#191 of 2,679).
Active Ingredients
Administration Routes
Species Affected
Most Affected Breeds
Most Reported Reactions
Outcome Breakdown
Ivermectin 136Mcg, Pyrantel Pamoate 114Mg, Praziquantel 114Mg: low death-coded share in the FDA AER row
Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.
High-volume nationwide drug peers
Two openFDA-derived peer sets for Ivermectin 136Mcg, Pyrantel Pamoate 114Mg, Praziquantel 114Mg, both floored at ≥50 reports so the neighborhoods stay in the advertised mass.
Similar report volume
Nearest other drugs by FDA report count (950 here).
Similar death-coded share
Nearest other drugs by death-coded share (1.4% here), distinct from the volume row.
What to do with this drug
- Compare Ivermectin 136Mcg, Pyrantel Pamoate 114Mg, Praziquantel 114Mg's report volume and death-coded share against similar drugs nationwide. See similar drugs
- Death-coded share and mortality rate measure different things -- see the distinction explained. Understanding adverse events
- See how this report count compares across the full drug directory. All drugs
A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →